Skip to main content
. 2021 Mar 16;11(3):245. doi: 10.3390/life11030245

Table 2.

Evaluated clinical parameters. DAS, disease activity score; SD, standard deviation; RA, rheumatoid arthritis; HDs, healthy donors; N, sample size.

Groups N Age
(Mean ± SD)
Male Female Duration
(Mean ± SD)
DAS-28
(Mean ± SD)
DAS-28 < 3.2 4 62.5 ± 18.9 - 4 15 ± 2.1 years 2.01 ± 0.82
DAS-28 > 3.2 9 59.1 ± 9.1 1 8 6 ± 4.6 years 5.58 ± 0.99
RA < 1 year 4 60 ± 4.5 - 4 9 ± 2 months 5.92 ± 1.61
RA > 1 year 9 59.7 ± 13.2 1 8 10.1 ± 4.8 years 4.10 ± 1.78
HD 18 56.4 ± 11 6 12 - -